Healthcare

Healthcare and Biotech

Biopharmaceutical R&D, genomics, clinical trials, drug discovery AI, and hospital operations software — the intersection of life sciences and technology.

5.2Good opportunity

Current Market

$1.5T

Today

Projected Market

$2.9T

2030 estimate

Growth Rate

14%

CAGR

Competition

6/10

Moderate

Market Size Trajectory

Unsolved Problems & SaaS Opportunities

3 problems · 6 ideas
1Problem

Clinical trial recruitment is the single largest cause of drug development delays — 80% of trials miss enrolment timelines, adding an average of 11 months and $8M in cost per delayed trial.

Critical10/10

SaaS Opportunities

TrialMatch

AI-powered patient recruitment platform that screens EHR records against eligibility criteria at population scale, surfaces pre-consented matched patients to site coordinators, and tracks enrolment in real time.

RevenuePer-patient-enrolled success fee plus site activation subscription

SiteSelect

Clinical trial site feasibility and performance prediction platform that ranks investigator sites by historical enrolment speed, patient population fit, and protocol complexity — before a single site contract is signed.

RevenueAnnual subscription per active trial programme for CROs and sponsors
2Problem

Drug discovery timelines average 12–15 years largely because target identification and lead optimisation cycles are slow — wet lab experiments are run sequentially with no AI prioritisation of candidates.

Critical9/10

SaaS Opportunities

MoleculeOS

AI-accelerated drug discovery platform that uses protein structure prediction and generative molecular design to propose and rank novel drug candidates against a target — reducing lead identification cycles from months to weeks.

RevenueResearch collaboration licensing plus per-programme milestone fees

AssayAI

Lab experiment prioritisation engine that integrates with LIMS to analyse historical assay data and predict which experimental conditions are most likely to yield active compounds — cutting lab time wasted on low-probability runs.

RevenueAnnual enterprise subscription per research programme
3Problem

Hospital supply chains run on just-in-time inventory with minimal buffers — a single supplier disruption creates critical shortages of drugs and devices, directly impacting patient safety.

Critical9/10

SaaS Opportunities

MedSupplyIQ

Hospital inventory resilience platform that monitors real-time drug and device stock levels across a health system, forecasts shortage risk 90 days out, and auto-triggers reorders from pre-approved alternative suppliers.

RevenueAnnual subscription per hospital by supply chain spend under management

PharmaTrace

Pharmaceutical supply chain traceability platform that tracks drug provenance from manufacturer to bedside, automating DSCSA compliance and flagging counterfeit or diverted product in real time.

RevenuePer-unit serialisation fee plus compliance dashboard subscription